Research & Resources

Peptides are short chains of amino acids (typically 2–50) that act as biological signaling molecules in the body. They can bind to specific receptors and trigger targeted physiological responses — such as stimulating tissue repair, modulating the immune system, or promoting growth hormone release. Therapeutic peptides mimic or amplify natural biological processes that may be diminished by injury, age, or disease.

No. All Montgomery Pharmaceuticals products are pharmaceutical-grade compounds intended exclusively for licensed healthcare professionals. Patients interested in peptide or stem cell therapies should consult with their healthcare provider, who can evaluate whether these treatments are appropriate.

Our products are regulated under the Food and Drugs Act and associated regulations in Canada. Where applicable, products are registered with Health Canada under Drug Identification Numbers (DINs). Our regulatory affairs team ensures full compliance at every stage.

Every batch undergoes: (1) HPLC for purity verification ≥98–99%; (2) Mass spectrometry to confirm molecular identity; (3) Sterility testing per USP <71> standards; (4) Bacterial endotoxin testing (BET/LAL assay); (5) Moisture content analysis. Certificates of Analysis (COA) are available for every batch.

Traditional stem cell therapy involves live cells intended to engraft and differentiate. Exosome therapy uses nano-sized vesicles secreted by stem cells that carry the same bioactive molecules without introducing live cells. Exosomes provide paracrine signaling benefits with a more favorable regulatory profile, off-the-shelf availability, and no immune rejection risk.

Complete our contact form. You will need: proof of professional licensure, clinic address, a signed professional agreement, and description of intended use. Accounts are typically activated within 3–5 business days.